BioRestorative Therapies (BRTX) Revenue (2012 - 2025)
BioRestorative Therapies' (BRTX) quarterly Revenue came in at $19600.0 in Q4 2025, down 54.73% YoY from $43300.0 in Q4 2024, and up 66.1% on a QoQ basis from $11800.0 in Q3 2025.
BioRestorative Therapies (BRTX) Revenue (2012 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 14 years of Revenue data on file, last reported at $19600.0 in Q4 2025.
- Quarterly Revenue fell 54.73% year-over-year to $19600.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $359700.0 (down 10.3% YoY) and the FY2025 annual result came in at $359700.0, down 10.3% from the prior year.
- Revenue rose to $19600.0 in Q4 2025, from $11800.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $303300.0 in Q2 2025 to a low of $3700.0 in Q4 2022.
- A 5-year average of $53615.0 and a median of $27000.0 in 2022 frame the typical range for Revenue.
- Annual changes were most pronounced in 2024 — Revenue surged 660.91% — and 2025, when it slumped 94.95%.
- Tracing BRTX's Revenue over 5 years: stood at $5000.0 in 2021, then retreated by 26.0% to $3700.0 in 2022, then soared by 421.62% to $19300.0 in 2023, then surged by 124.35% to $43300.0 in 2024, then tumbled by 54.73% to $19600.0 in 2025.
- The last three Revenue figures came in at $19600.0 (Q4 2025), $11800.0 (Q3 2025), and $303300.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | BioRestorative Therapies | 2.00 Mn | -953,752.60 | 17,964.00 | 19,600.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19,600.00 |
| Sep 30, 2025 | 11,800.00 |
| Jun 30, 2025 | 303,300.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 43,300.00 |
| Sep 30, 2024 | 233,600.00 |
| Jun 30, 2024 | 89,100.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | 19,300.00 |
| Sep 30, 2023 | 30,700.00 |
| Jun 30, 2023 | 64,500.00 |
| Mar 31, 2023 | 31,300.00 |
| Dec 31, 2022 | 3,700.00 |
| Sep 30, 2022 | 29,000.00 |
| Jun 30, 2022 | 71,100.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 15,000.00 |
| Mar 31, 2021 | 18,000.00 |